Joseph Iglesias has joinedBioElectronics(Frederick, Maryland), a developer of drug-free, anti-inflammatory patches, as vice president of design and engineering. Formerly, Iglesias was manager of product design for Royce Medical. A specialist in bioengineering and ergonomic design, he has developed more than 20 products in the fields of orthopedics, sports medicine, podiatry, chronic wound care and rehabilitation that have resulted in more than 25 patents in the U.S. and worldwide.

Darryl Galman has been named director of managed care contracting for Cirrus Health (Trophy Club, Texas). Prior to joining Cirrus Health, Galman served with United Surgical Partners International as regional director of managed care. Cirrus Health is a healthcare development and management company specializing in ambulatory surgery centers, surgical hospitals, imaging centers and medical office buildings.

The Department of Health and Human Services (HHS; Washington) appointed Douglas O’Brien as the secretary’s regional director for Region 5, based in Chicago. O’Brien will be the secretary’s representative responsible for guidance and coordination of HHS policies in the region, which includes Illinois, Indiana, Michigan, Minnesota, Ohio and Wisconsin. O’Brien previously served as chief of staff for U.S. Congressman Mark Kirk, 10th District of Illinois.

• Greatbatch (Clarence, New York) reported the departure of Lawrence Reinhold, who had served the company for three years as executive vice president and CFO. Thomas Mazza, vice president and corporate controller, will assume the position of acting CFO. Greatbatch manufactures critical components used in implantable medical devices.

Jason Hannon has been named to the newly created position of vice president of legal affairs for NuVasive (San Diego). Hannon will also serve as the secretary to the board of directors and as a member of the executive management committee. Prior to NuVasive, Hannon was employed by Heller Ehrman, a San Francisco-based law firm. NuVasive develops products for minimally disruptive surgical treatments for the spine.